Vitacoin project roadmap

The roadmap allows us to explain the levels and criteria as well as goals of investment in Vitacoins in lay language and in detail.

Level
Level criteria and description
Actions for Project implementation at each level
1
Project start level. The task is to recruit 1000 participants or 100,000 Vitacoins
Minimum amount accumulation on the deposit for further activities implementation. Team building start, holding of meetings with interested scientists, investors; develop own services and products.
2
Project dynamics. 10,000 users and 1 million Vitacoins
Project advertising and promotion to attract new users. Solution continuation of our own services and products as per the project mission. Actual team building and blockchain creation with connected ERP system
3
Start of investment. 25,000 users and 2.5 million Vitacoins
Beginning of received fund, Investment in projects of the biotechnology and pharmaceutical industry. Raising the issue for discussion related to the additional funding of existing own services and products and/or creation/acquisition of new ones. Partnership agreement undertaking with leading institutes and laboratories. Creating unified database of research and development 
4
Investing in private projects. 250,000 users and 25 million Vitacoins
Investment of 25% of funds in private companies of the biotechnology and pharmaceutical industry (25% - private market, 75% - public market). Public Discussion of issues on creating own laboratory for work of scientists, on the basis of which in future a Science Center will be created
5
Research center(s) establishment. 2.5 million users and 250 million Vitacoins
Investments in creation of a decentralized Science Center - the main global platform for developing anti-aging technologies with up to 20% of funds (15% - venture projects, 20% - Science Center, 15% - private companies, 50% - public companies). Transfer of all existing intangible assets to the Science Center
6
Systematization of all knowledge, technologies, longevity experiments, roadmap development, supported by the scientific community. 5 million users and 5 billion Vitacoins
Diversification of investments, additional capitalization of the scientific component (20% - venture projects, 25% - Science Center, 20% - private companies, 35% - public companies).
7
The era of Vitacoins embedding into the global venture capital field. 10 million users and 10 billion Vitacoins
Diversification of investments, additional capitalization of the scientific component (25% - venture projects, 35% - Science Center, 20% - private companies, 20% - public companies).
8
Creation of a new decentralized structure uniting science, development and production. 50 million users and 50 billion Vitacoins.
Project breakeven point, profit from previous investments. Possible IPO
9
Community development, access to a new level of permanent residents. 100 million users and 100 billion Vitacoins.
Science Center Formation as the world research core in the field of anti-aging mechanism. Friendly acquisition of research laboratories and innovative private companies engaged in anti-aging research by the Science Center. Initiate a community discussion on transferring research results to community members
10
Development of a modern high-tech base for life prolongation. 250 million users and 250 billion Vitacoins
Development of nano- and bioelectronics, as well as new biomaterials. Use of artificial intelligence to create highly effective personal medicines against diseases. AI use to create tools and therapy against aging.
11
Connection to the decentralized structure of leading research centers. 500 million users and 500 billion Vitacoins
The Science Center is becoming a central element of a whole network of development centers around the world, whose works are controlled by the community through a decentralized network.
12
Improving life propagation technologies. 1 billion users and 1 trillion Vitacoins
Development of life propagation tools with the use of artificial intelligence.
13
For the first time, project participants are acquainted with the results of drug development or life propagation technology. 2.5 billion users and 2.5 trillion Vitacoins
Investment Diversification, additional capitalization of the scientific component (30% - venture projects, 50% - Science Center, 20% - private companies).
14
The life propagation medicine becomes more accessible for everyone. 5 billion users and 5 trillion Vitacoins.
All assets are concentrated in the Science Center (100% of funds).
15
Victory over all diseases, almost no limit to human life. 10 billion users and 10 trillion Vitacoins
Pharmaceutical and biotech companies are not competitive with anti-aging drugs.
"Live Forever or Die Trying"